<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The echinocandins provide an attractive new option for prophylactic and empirical treatment of invasive <z:e sem="disease" ids="C0026946" disease_type="Disease or Syndrome" abbrv="">fungal infections</z:e> in patients with <z:hpo ids='HP_0001875'>neutropenia</z:hpo> after intensive cytotoxic chemotherapy or hematopoietic stem cell transplantation </plain></SENT>
<SENT sid="1" pm="."><plain>We present two patients with <z:e sem="disease" ids="C0018939" disease_type="Disease or Syndrome" abbrv="">hematological diseases</z:e> who experienced massive intravascular <z:mp ids='MP_0010163'>hemolysis</z:mp> followed by <z:hpo ids='HP_0000083'>renal failure</z:hpo> after administration of micafungin </plain></SENT>
<SENT sid="2" pm="."><plain>In indirect antiglobulin test, significant agglutination was observed when red blood cells were exposed to the mixture of micafungin and either of the patients' plasma samples, indicating that production of antibodies directed against both micafungin and red blood cell membrane induced <z:mp ids='MP_0010163'>hemolysis</z:mp> attack </plain></SENT>
<SENT sid="3" pm="."><plain>Micafungin-mediated immune <z:mp ids='MP_0010163'>hemolysis</z:mp> represents an uncommon but life-threatening adverse reaction leading to <z:hpo ids='HP_0000083'>renal failure</z:hpo> </plain></SENT>
</text></document>